Avidity Biosciences, Inc. (RNA) Description, Stock price, News & Info.

#ThinkSabio Latest News

RNA Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with DMD Amenable to Exon 44 Skipping in Phase 1/2 EXPLORE44 Trial

Leave a Reply

Your email address will not be published. Required fields are marked *